“We ended 2025 stronger, with 8% revenue growth supported by 43% year over year growth in our international medical cannabis business and a robust platform designed for regulated markets,” said Greg Hunter, CFO and Interim CEO of MediPharm Labs. Read More
Invest Smart Edge
Finance and Investment